OptimizeRx Corporation (OPRX)
NASDAQ: OPRXConsumer DiscretionaryBusiness ServicesUSD
Market open · Delayed 15 min · as of Oct 8, 3:23 PM ET
OPRX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $159.45M
- P/E (TTM)
- 35.27
- Forward P/E
- 8.11
- EPS (TTM)
- $0.24
- Dividend yield
- None
- 52-week range
- 4.54 – 22.25
- Day range
- 8.20 – 8.52
- Volume / Avg
- 81.53K / 207.31K
- Beta
- —
- Shares outstanding
- 18.84M
- Next earnings
- Nov 5, 2026
52-week range
OPRX stock today
On Oct 8, OPRX is trading at $8.47, shedding $0.085 (0.99%), versus the S&P 500's 0.52% decline. Shares are 62.0% below their 52-week high of $22.25, set on Oct 27, 2025 and 86.5% above the 52-week low of $4.54, in the middle of the past year's range. OPRX is down 30.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 52.4%.
OptimizeRx trades at 35.3x its trailing twelve-month earnings per share of $0.24. Its forward P/E of 8.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. OptimizeRx's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About OptimizeRx
Company profileOptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms.
- Sector
- Consumer Discretionary
- Industry
- Business Services
- CEO
- Mr. Stephen L. Silvestro
- Headquarters
- Waltham, MA
- Employees
- 132
- Website
- optimizerx.com
Analyst forecast
ForecastConsensus (6 analysts)
strong_buy
Avg. price target
$12.60+48.85%
- Strong buy 1
- Buy 5
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.07
OptimizeRx peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DVLTDatavault AI Inc. | 0.1473 | -4.66% | $139.90M | vs OPRX |
| RYDERyde Group Ltd. Class A | 0.673 | -7.81% | $121.29M | vs OPRX |
| AMWLAmerican Well Corporation Class A | 12.49 | -1.19% | $212.44M | vs OPRX |
| DHXDHI Group Inc. | 4.96 | +2.06% | $214.26M | vs OPRX |
| RGPResources Connection Inc. | 2.97 | -20.48% | $102.43M | vs OPRX |
| TDTHTrident Digital Tech Holdings Ltd Class B | 0.9308 | -8.75% | $101.59M | vs OPRX |
| CNDTConduent Incorporated | 1.56 | -2.81% | $241.83M | vs OPRX |
| UXINUxin Limited ADS | 1.10 | -9.09% | $241.98M | vs OPRX |
Indexes, lists and sector
Largest Consumer Discretionary stocks
OptimizeRx stock FAQ
What is OptimizeRx's stock price today?
OPRX last traded at $8.47 as of Oct 8, 3:23 PM EDT, down 0.99% on the day. Prices are delayed at least 15 minutes.
Does OptimizeRx pay a dividend?
No. OptimizeRx does not currently pay a regular cash dividend.
When is OptimizeRx's next earnings date?
OptimizeRx is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.07.
What is OPRX's P/E ratio?
OPRX trades at a trailing P/E ratio of 35.27 and a forward P/E of 8.11.
Who is OptimizeRx's CEO?
Mr. Stephen L. Silvestro is the chief executive officer of OptimizeRx Corporation, which has about 132 employees.
Has OPRX ever split its stock?
Yes. The most recent OPRX stock split was a 1-for-3 split on May 14, 2018.
What is the OPRX 52-week high?
The 52-week high for OPRX is $22.25 and the 52-week low is $4.54. The stock is currently 62.0% below its high.